Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced members of its executive team are scheduled to participate in the upcoming conference, detailed below. Participants will include Yannis Morel, EVP, Chief Operating Officer and Arvind Sood, EVP, President of US Operations.
BTIG Virtual Biotechnology Conference
Dates: August 5 - 6 2024 | Virtual
| Press release in English | 176.81 KB |
| Communiqué de presse en français | 134.3 KB |